Back to discover
Drug
Octopamine
Research stageEmerging research
Also known as Norsynephrine.
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Synapse-specific catecholaminergic modulation of neuronal glutamate release.
Research2024-12-30Proceedings of the National Academy of Sciences of the United States of America
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Octopamine
Aliases & brands
Norsynephrine
RxNorm CUI
1311141
ChEMBL ID
CHEMBL53929
ATC codes
C01CA18
UNII
14O50WS8JD
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Glutamic Acid1Motor Neurons1Octopamine1Receptors, Biogenic Amine1Synapses1
Journals, researchers & institutions
Top journals
- Proceedings of the National Academy of Sciences of the United States of America1
Leading researchers
- Bakshinska D1
- Cypranowska C1
- Hoagland A1
- Isacoff EY1
- Liu WY1
- Newman ZL1
- Schultz R1
- Stanley C1
Leading institutions
free-text, unnormalised
- Helen Wills Neuroscience Institute1
- Lawrence Berkeley National Laboratory1
- Montana State University1
- University of California1
- University of California Berkeley1
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature